T/CACM 014-2017 Coronary Atherosclerotic Heart Disease with Phlegm-Dampness Syndrome Clinical Diagnostic Criteria

Scope

Main technical content: According to the "China Cardiovascular Disease Report 2015", cardiovascular diseases (CVD) ranked first in the cause of death in China in 2014. The "2015 China Health and Family Planning Statistical Yearbook" showed that the mortality rate of coronary atherosclerotic heart disease (hereinafter referred to as "coronary heart disease") in China in 2014 was 107.5/100,000 in urban areas and 105.37/100,000 in rural areas, both of which increased compared with 2013 (100.86/100,000 and 98.68/100,000, respectively). With the changes in lifestyle, the proportion of phlegm-related syndromes in coronary heart disease has been increasing. However, in the previous diagnosis standards of coronary heart disease related to phlegm syndrome (see Appendix A), there are problems such as the lack of a unified diagnostic standard, the lack of standardized terminology related to "phlegm", and the misidentification of "phlegm-dampness" as "phlegm-wetness", as well as the lack of diagnostic weight for various items, which affect its application in clinical practice and scientific research. To implement the important task of "comprehensively promoting the construction of a standard system for traditional Chinese medicine" proposed in the "Medium- and Long-term Development Plan for Standardization of Traditional Chinese Medicine (2011-2020)", and give full play to the advantages of traditional Chinese medicine in the prevention and treatment of coronary heart disease, this standard, based on a systematic review of previous diagnosis standards related to phlegm syndrome in coronary heart disease, uses the analytic hierarchy process (AHP) to collect expert opinions through on-site surveys, combines multiple rounds of discussions and demonstrations, and determines the clinical diagnosis items and their weights for phlegm-wetness syndrome in coronary heart disease, thereby improving the diagnosis standards related to phlegm syndrome in coronary heart disease and providing

Development Information

Related Standards